@AnavexLifeSci Anavex Life Sciences to initiate Phase 2 Study of ANAVEX®2-73 in Parkinson’s Disease Dementia and Provides Clinical… twitter.com/i/web/status/9…
@AnavexLifeSci Anavex Life Sciences to Present at the 30th Annual ROTH Conference goo.gl/9nnnDA… twitter.com/i/web/status/9…
@AnavexLifeSci Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experim… twitter.com/i/web/status/9…